"Mr. Moscato stated, “ It is unfortunate and with deep sadness that I have to postpone this dividend due to the actions of certain parties that have resulted in a significant decline in our share value. On Friday’s call, I will provide details of the actions and circumstances that have caused this postponement and discuss options for new dates to issue the dividend. Because one investment group that signed the dividend waiver engaged in questionable business practices on the sale of GNBT shares in this pre-dividend period, shareholders, and other stakeholders who signed waivers, including investors, management, acquisitions, and subsidiaries have been disadvantaged. We have focused our efforts over the last three years to to build value in Generex, and we are committed to sharing our successes with our shareholders in the form of dividends. However, paying a dividend now will not build value, and it may restrict our ability to complete our plan to bring Generex back to Nasdaq. I will discuss this with our shareholders on Friday’s call, and will provide additional information as it becomes available. And as always, I look forward to answering all of your questions.”
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links